The labeling updates address the risk of early-onset toxicity, including life-threatening adverse events in patients with DPD deficiency who are treated with the drugs.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/fda-updates-risks-capecitabine-fluorouracil-labels-2026a10003v0?src=rss
Author :
Publish date : 2026-02-06 18:44:00
Copyright for syndicated content belongs to the linked Source.